Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors

Annals of Surgical Oncology

Volumn 11, Issue 11, 2004, Pages 1011-1017

  Asoglu, Oktar ^a   Ugurlu, Mustafa M ^a   Blanchard, Kay ^a   Grant, Clive S ^a   Reynolds, Carol ^a   Cha, Steven S ^a   Donohue, John H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast; Local recurrence; Malignant phyllodes; Surgical treatment

Indexed keywords

DOXORUBICIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; REVIEW; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; ARTICLE; BREAST TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PHYLLODES TUMOR; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 16644371719     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.02.001     Document Type: Review

References (42)

1. Rowell MD, Perry RR, Hsiu JG, Barranco SC. Phyllodes tumors. Am J Surg 1993;165:376-9.
2. Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996;77:910-6.
3. Moffat CJ, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 1995;27:205-18.
4. Chaney AW, Pollack A, McNeese MD, et al. Primary treatment for cystosarcoma phyllodes of the breast. Cancer 2000;89:1502-11.
5. Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silversward C. Prognostic factors in cystosarcoma: a clinicopathologic study of 77 patients. Cancer 1991;68:2017-22.
6. Salvadori B, Cusumano F, Del Bo R, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989;63:2532-6.
7. Zissis C, Apostolikas N, Konstantinidou A, Griniatsos J, Vassilopoulos PP. The extent of surgery and prognosis of patients with phyllodes tumor of the breast. Breast Cancer Res Treat 1998;48:205-10.
8. Palmer ML, De Risi DC, Pelikan A, et al. Treatment options and recurrence potential for cystosarcoma phyllodes. Surg Gynecol Obstet 1990;170:193-6.
9. Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am J Surg Pathol 1998;22:64-9.
10. Modena S, Prati G, Mainente M, et al. Phyllodes tumor of the breast: problems of differential diagnosis and therapeutic approach from an analysis of 17 cases. Eur J Surg Oncol 1993;19:70-3.
11. Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol 1979;11:1-466.
12. Turalba CI, el-Mahdi AM, Ladaga L. Fatal metastatic cystosarcoma phyllodes in an adolescent female: case report and review of treatment approaches. J Surg Oncol 1986;33:176-81.
13. Faraci RP, Schour L. Radical treatment of recurrent cytosarcoma phylloides. Ann Surg 1974;180:796-8.
14. Hajdu SI, Espinosa MH, Robbins GF. Recurrent cystosarcoma phyllodes: a clinicopathologic study of 32 cases. Cancer 1975;38:1402-5.
15. Fernandez BB, Hernanzez FJ, Spindler W. Metastatic cystosarcoma phyllodes: a light and electron microscopic study. Cancer 1976;37:1737-46.
16. Vorherr H, Vorherr UF, Kutvirt DM, Key CR. Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival. Arch Gynecol 1985;236:173-81.
17. Pandey M, Mathew A, Kattoor J, et al. Malignant phyllodes tumor. Breast J 2001;7:411-6.
18. Kapiris I, Nasiri N, A'Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 2001;27:723-30.
19. Reinfuss M, Mitus J, Smolak K, Stelmach A. Malignant phyllodes tumours of the breast. A clinical and pathological analysis of 55 cases. Eur J Cancer 1993;29A:1252-6.
20. Ciatto S, Bonardi R, Cataliotti L, Cardona G. Phyllodes tumor of the breast: a multicenter series of 59 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Eur J Surg Oncol 1992;18:545-9.
21. Zurrida S, Bartoli C, Galimberti V, et al. Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer 1992;28:654-7.
22. Stebbing JF, Nash AG. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl 1995;77:181-4.
23. Staren ED, Lynch G, Boyle C, Witt TR, Bines SD. Malignant cystosarcoma phyllodes. Am Surg 1994;60:583-5.
24. Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 1999;57:291-5.
25. Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes: a review of surgical options. Surgery 1989;105:141-7.
26. Hines JR, Murad TM, Beal JM. Prognostic indicators in cystosarcoma phylloides. Am J Surg 1987;153:276-80.
27. Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 1992;5:232-9.
28. Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW. Surgical management of phyllodes tumors. Arch Surg 1999;134:487-92.
29. Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 1978;41:1974-83.
30. Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J 2001;77:428-35.
31. Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer 1967;20:2090-9.
32. Hawkins RE, Schofield JB, Fisher C, Wiltshaw E, McKinna JA. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer 1992;69:141-7.
33. West TL, Weiland LH, Clagett OT. Cystosarcoma phyllodes. Ann Surg 1971;173:520-8.
34. Ward RM, Evans HL. Cystosarcoma phyllodes. A clinicopathologic study of 26 cases. Cancer 1986;58:2282-9.
35. Kario K, Maeda S, Mizuno Y, Makino Y, Tankawa H, Kitazawa S. Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. J Surg Oncol 1990;45:46-51.
36. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 1993;53:4071-4.
37. Burton GV, Hart LL, Leight GS Jr, Iglehart JD, McCarty KS Jr, Cox EB. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer 1989;63:2088-92.
38. Hopkins ML, McGowan TS, Rawlings G, et al. Phylloides tumor of the breast: a report of 14 cases. J Surg Oncol 1994;56:108-12.
39. Stockdale AD, Leader M. Phyllodes tumour of the breast: response to radiotherapy. Clin Radiol 1987;38:287.
40. August DA, Kearney T. Cystosarcoma phyllodes: mastectomy, lumpectomy, or lumpectomy plus irradiation. Surg Oncol 2000;9:49-52.
41. Guerrero MA, Ballard BR, Grau AM. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. Surg Oncol 2003;12:27-37.
42. Contarini O, Urdaneta LF, Hagan W, Stephenson SE Jr. Cystosarcoma phylloides of the breast: a new therapeutic proposal. Am Surg 1982;48:157-66.